Stellantis facing sales drops post-pandemic, not recommended by Motley Fool

From Nasdaq: 2024-12-04 11:28:46

Stellantis (NYSE: STLA) is facing sales drops due to strategic difficulties post-pandemic recovery. Should investors buy $1,000 in Stellantis? Motley Fool’s Stock Advisor team recommends 10 other stocks for potential monster returns, excluding Stellantis. Stock Advisor service has quadrupled S&P 500 returns since 2002.

Investment analyst Travis Hoium holds positions in General Motors. The Motley Fool endorses Tesla, General Motors, Stellantis, and Volkswagen Ag, recommending options for long January 2025 $25 calls on General Motors. Hoium may earn compensation for promoting The Motley Fool’s services. Opinions expressed are independent of The Motley Fool.



Read more at Nasdaq: Stellantis Is Headed for Disaster